RATIONALE: Resuscitation-promoting factors (Rpfs) are a family of secreted proteins produced by Mycobacterium tuberculosis (Mtb) that stimulate mycobacterial growth. Although mouse infection studies show that they support bacterial survival and disease reactivation, it is currently unknown whether Rpfs influence human infection. We hypothesized that tuberculous sputum might include a population of Rpf-dependent Mtb cells. OBJECTIVES: To determine whether Rpf-dependent Mtb cells are present in human sputum and explore the impact of chemotherapy on this population. METHODS: In tuberculous sputum samples we compared the number of cells detected by conventional agar colony-forming assay with that determined by limiting dilution, most-probable number assay in the presence or absence of Rpf preparations. MEASUREMENTS AND MAIN RESULTS: In 20 of 25 prechemotherapy samples from separate patients, 80-99.99% of the cells demonstrated by cultivation could be detected only with Rpf stimulation. Mtb cells with this phenotype were not generated on specimen storage or by inoculating sputum samples with a selection of clinical isolates; moreover, Rpf dependency was lost after primary isolation. During chemotherapy, the proportion of Rpf-dependent cells was found to increase relative to the surviving colony-forming population. CONCLUSIONS: Smear-positive sputum samples are dominated by a population of Mtb cells that can be grown only in the presence of Rpfs. These intriguing proteins are therefore relevant to human infection. The Rpf-dependent population is invisible to conventional culture and is progressively enhanced in relative terms during chemotherapy, indicating a form of phenotypic resistance that may be significant for both chemotherapy and transmission.
RATIONALE: Resuscitation-promoting factors (Rpfs) are a family of secreted proteins produced by Mycobacterium tuberculosis (Mtb) that stimulate mycobacterial growth. Although mouseinfection studies show that they support bacterial survival and disease reactivation, it is currently unknown whether Rpfs influence humaninfection. We hypothesized that tuberculous sputum might include a population of Rpf-dependent Mtb cells. OBJECTIVES: To determine whether Rpf-dependent Mtb cells are present in human sputum and explore the impact of chemotherapy on this population. METHODS: In tuberculous sputum samples we compared the number of cells detected by conventional agar colony-forming assay with that determined by limiting dilution, most-probable number assay in the presence or absence of Rpf preparations. MEASUREMENTS AND MAIN RESULTS: In 20 of 25 prechemotherapy samples from separate patients, 80-99.99% of the cells demonstrated by cultivation could be detected only with Rpf stimulation. Mtb cells with this phenotype were not generated on specimen storage or by inoculating sputum samples with a selection of clinical isolates; moreover, Rpf dependency was lost after primary isolation. During chemotherapy, the proportion of Rpf-dependent cells was found to increase relative to the surviving colony-forming population. CONCLUSIONS: Smear-positive sputum samples are dominated by a population of Mtb cells that can be grown only in the presence of Rpfs. These intriguing proteins are therefore relevant to humaninfection. The Rpf-dependent population is invisible to conventional culture and is progressively enhanced in relative terms during chemotherapy, indicating a form of phenotypic resistance that may be significant for both chemotherapy and transmission.
Authors: F A Sirgel; P R Donald; J Odhiambo; W Githui; K C Umapathy; C N Paramasivan; C M Tam; K M Kam; C W Lam; K M Sole; D A Mitchison Journal: J Antimicrob Chemother Date: 2000-06 Impact factor: 5.790
Authors: M O Shleeva; K Bagramyan; M V Telkov; G V Mukamolova; M Young; D B Kell; A S Kaprelyants Journal: Microbiology Date: 2002-05 Impact factor: 2.777
Authors: S Biketov; G V Mukamolova; V Potapov; E Gilenkov; G Vostroknutova; D B Kell; M Young; A S Kaprelyants Journal: FEMS Immunol Med Microbiol Date: 2000-12
Authors: I L Bartek; R Rutherford; V Gruppo; R A Morton; R P Morris; M R Klein; K C Visconti; G J Ryan; G K Schoolnik; A Lenaerts; M I Voskuil Journal: Tuberculosis (Edinb) Date: 2009-07-03 Impact factor: 3.131
Authors: Eddy S G Cheah; Joanne Malkin; Robert C Free; Su-Min Lee; Nelun Perera; Gerrit Woltmann; Hemu Patel; Patrick T Kimmitt; Rebecca J Smith; Kumar Rajakumar; Michael R Barer Journal: J Mol Diagn Date: 2010-01-21 Impact factor: 5.568
Authors: Sonia A Gomez; Claudia L Argüelles; Diego Guerrieri; Nancy L Tateosian; Nicolás O Amiano; Rut Slimovich; Paulo C Maffia; Eduardo Abbate; Rosa M Musella; Verónica E Garcia; H Eduardo Chuluyan Journal: Am J Respir Crit Care Med Date: 2008-11-14 Impact factor: 21.405
Authors: Obolbek Turapov; Sarah Glenn; Bavesh Kana; Vadim Makarov; Peter W Andrew; Galina V Mukamolova Journal: Am J Respir Crit Care Med Date: 2014-12-15 Impact factor: 21.405
Authors: Andrew Rosser; Manish Pareek; Obolbek Turapov; Martin J Wiselka; Galina V Mukamolova Journal: Am J Respir Crit Care Med Date: 2018-03-15 Impact factor: 21.405
Authors: Nicholas D Walter; Gregory M Dolganov; Benjamin J Garcia; William Worodria; Alfred Andama; Emmanuel Musisi; Irene Ayakaka; Tran T Van; Martin I Voskuil; Bouke C de Jong; Rebecca M Davidson; Tasha E Fingerlin; Katerina Kechris; Claire Palmer; Payam Nahid; Charles L Daley; Mark Geraci; Laurence Huang; Adithya Cattamanchi; Michael Strong; Gary K Schoolnik; John Lucian Davis Journal: J Infect Dis Date: 2015-03-11 Impact factor: 5.226